Toward a More Accurate Estimate of the Prevalence of Hepatitis C in the United States
Overview
Affiliations
Unlabelled: Data from the 2003-2010 National Health and Nutrition Examination Survey (NHANES) indicate that about 3.6 million people in the United States have antibodies to the hepatitis C virus, of whom 2.7 million are currently infected. NHANES, however, excludes several high-risk populations from its sampling frame, including people who are incarcerated, homeless, or hospitalized; nursing home residents; active-duty military personnel; and people living on Indian reservations. We undertook a systematic review of peer-reviewed literature and sought out unpublished presentations and data to estimate the prevalence of hepatitis C in these excluded populations and in turn improve the estimate of the number of people with hepatitis C in the United States. The available data do not support a precise result, but we estimated that 1.0 million (range 0.4 million-1.8 million) persons excluded from the NHANES sampling frame have hepatitis C virus antibody, including 500,000 incarcerated people, 220,000 homeless people, 120,000 people living on Indian reservations, and 75,000 people in hospitals. Most are men. An estimated 0.8 million (range 0.3 million-1.5 million) are currently infected. Several additional sources of underestimation, including nonresponse bias and the underrepresentation of other groups at increased risk of hepatitis C that are not excluded from the NHANES sampling frame, were not addressed in this study.
Conclusion: The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million (range 3.4 million-6.0 million), and of these, at least 3.5 million (range 2.5 million-4.7 million) are currently infected; additional sources of potential underestimation suggest that the true prevalence could well be higher.
Zhang C, Lu J, Zhang Y, He P, Xia J, Huang M Liver Res. 2025; 6(4):284-288.
PMID: 39957907 PMC: 11791864. DOI: 10.1016/j.livres.2022.12.003.
Association between history of viral infections and melanoma mortality.
Shen N, Creveling P, Horns J, Bleicher J, Hyngstrom J, Bowles T Heliyon. 2024; 10(22):e40353.
PMID: 39619574 PMC: 11605399. DOI: 10.1016/j.heliyon.2024.e40353.
A Road Map to Hepatitis C Elimination: Yesterday, Today, and Tomorrow.
Gonzalez Corro L, Lucas G, Page K Open Forum Infect Dis. 2024; 11(11):ofae661.
PMID: 39582499 PMC: 11584410. DOI: 10.1093/ofid/ofae661.
Retrospective study evaluating association of colorectal tumors and hepatitis C virus.
Gogtay M, Yadukumar L, Singh Y, Suresh M, Soni A, Yekula A World J Virol. 2024; 13(3):92647.
PMID: 39323450 PMC: 11401003. DOI: 10.5501/wjv.v13.i3.92647.
Ozturk N, Pham H, Mouhaffel R, Ibrahim R, Alsaqa M, Gurakar A Viruses. 2024; 16(5).
PMID: 38793576 PMC: 11125803. DOI: 10.3390/v16050694.